NCIMB Secures £1.7m Funding to Boost Microbiology Services

NCIMB Limited, an Aberdeen-based microbiology services provider, has secured £1.7 million in growth funding from the Investment Fund for Scotland (IFS) and the Scottish National Investment Bank, managed by Maven Capital Partners. The company, known for its extensive industrial, food, and marine bacterial culture collection, plans to use the funds to enhance its core microbiology and strain licensing services. NCIMB aims to expand its service offerings to include selecting and developing bacterial strains for customer-specific applications. CEO Edward Green emphasizes that the funding is instrumental in scaling operations in Northeast Scotland and supporting innovations that address major global issues like climate change and food security. David Milroy, a partner at Maven, notes that the investment aligns with NCIMB's reputation for high-quality microbiological services and positions the company to meet the rising demand for Contract Research Organisations (CRO) with specialized expertise. This funding will enable NCIMB to broaden its commercial reach, licensing capabilities, and service range worldwide.